Rapid Nutrition PLC · EURONEXT:ALRPD
Rapid Nutrition — Investor Presentation (2025)
19 slides from Rapid Nutrition's investor presentation, Jun 25, 2025
Slide 1: Rapid Nutrition Corporate Presentation 2025
2025 © Rapid Nutrition PLC and it’s related entities
Slide 2: Legal Disclaimer
Legal Disclaimer Forward-Looking Statements This presentation includes forward-looking statements made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and assumptions that could cause Rapid Nutrition PLC's actua
Slide 3: About Us
About Us Rapid Nutrition is an innovative HealthTech company dedicated to enhancing global health. We create evidence-based, personalized nutrition solutions using advanced technologies, AI, and scientific research. Our aim is to optimize nutrition, improve wellness, and support sustainable, healthi
Slide 4: Key Milestones
Key Milestones Between 2004 and 2024, secured export sales and product registrations in multiple countries, including China, Korea, Singapore, Thailand, India, Ghana, the UK, Ireland, Poland, the Czech Republic, Turkey, South Africa, and the USA. Developed and Secured licensing Secured national dist
Slide 5: Board of Directors
Board of Directors Proven track record Simon St Ledger – Executive Director and CEO Simon St. Ledger, a personal trainer and dietary consultant with over 20 years of experience, has advised numerous health clubs and organizations. He managed national fitness equipment suppliers and co-founded the Au
Slide 6: Management
Management Entrepreneurial led management team Carl Seletz – Advisory Member Carl is a global brand, retail, and operations executive with over 35 years of experience. He most recently served as Chief Global Officer at GNC (2019-2021), overseeing retail, wholesale, distribution, digital, e-commerce,
Slide 7: Investment Proposition
Investment Proposition Poised for Growth Why Invest? • The life sciences and nutraceutical sectors emphasize quality control, a strong value chain, and scalable efficacy. The global nutraceutical market is projected to reach $450-460 billion by 2032 Diversification Scalable • A strong track record o
Slide 8: Growing Product Portfolio
Growing Product Portfolio An innovative HealthTech company dedicated to enhancing global health. We create evidence-based, personalized nutrition solutions using advanced technologies, AI, and scientific research. Our aim is to optimize nutrition, improve wellness, and support sustainable, healthier
Slide 9: © R ap id Nu trit ion PL C and it ’s related en
© R ap id Nu trit ion PL C and it ’s related en titi es
Slide 10: Azurene Immunity Boost Traveller
Azurene Immunity Boost Traveller features a patented blend of traditional Western and Chinese herbal remedies designed to reduce the severity and duration of mild upper respiratory infections, such as colds and the flu. Enhanced with Ashwagandha and Andrographis, it strengthens immune defenses and m
Slide 11: Awards
Awards • Recipient of the Entrepreneur Grant 2021 and Innovation Grant 2020 • Finalist for Product of the Year 2017 • Finalist at the Health & Biotechnology Awards 2016 • National Finalist at the 51st Australian Export Awards 2013 • Winner of the Premier of Queensland’s Export Awards 2013 • Finalist
Slide 12: Global Manufacturing
Global Manufacturing Drives certified quality Improve Gross Margins Australia – TGA and GMP-certified contract manufacturing Mitigate logistical agreements in place risks USA – Multiple FDA and GMP-certified contract manufacturing agreements in place to ensure a consistent supply that meets Efficien
Slide 13: Expanding Distribution Network
Expanding Distribution Network Geographic diversification • Secured key international accounts through a strategic partnership with Super Health Center, USA, a leading global distribution company • Expanded distribution channels through retailers and online e-commerce platforms, including Amazon • N
Slide 14: Trusted Brand
Trusted Brand Innovation and Cooperation Rapid N utrition, a g lobal lead er in prem ium nutrition prod ucts, proudly announces its s election as a key partner in the g round-breaking Osteoarthritis Prevention S tud y (TOPS ) led by Wa ke Forest U nivers ity.This s ig nificant collaboration hig hlig
Slide 15: Digital Strategies
Digital Strategies Marketing for growth Traditional & Digital Media © Rapid Nutrition PLC and it’s related entities
Slide 16: R&D & Product Development
R&D & Product Development “Growing IP” • Evidence Based – Participating in large-scale clinical study “Fully Certified” Intellectual Property – Expanding the international • portfolio “Optimizing AzureneTM – is an oral treatment designed to help established combat the common cold in humans. The prod
Slide 17: Financial Highlights
Financial Highlights Diverse channel platform Key financial highlights from the audited 2023 results are as follows: ❖ Direct-to-Consumer (DTC) Channels Fuel Revenue Growth: Rapid Nutrition achieves notable financial milestones with robust online revenue growth through DTC channels in FY2023 ❖ Stron
Slide 18: Conclusion
Conclusion Poised for Growth Expanding distribution Expanding product portfolio Strategic acquisitions • Organic growth - Expanding the company’s nutraceuticals product range to drive increased sales volume in both domestic and international markets • Expanding manufacturing capacity to meet growing
Slide 19: Contact
2 Contact Follow us Investor Relations Contact:: ir@rnplc.com | http://www.rnplc.com